This invention relates to methods for treating bacterial infection which methods find utility in the treatment of for example infected ulcers optionally infected diabetic ulcers. In particular this invention relates to treating bacterial infection for example infected diabetic ulcers by topical administration of at least one aminoglycoside antibiotic at the site of infection in combination with at least one antibacterial agent which antibacterial agent is administered remote from the site of inf...

This invention relates to methods for treating bacterial infection, which methods find utility in the treatment of, for example, infected ulcers, optionally infected diabetic ulcers. In particular, this invention relates to treating bacterial infection, for example, infected diabetic ulcers by topical administration of at least one aminoglycoside antibiotic at the site of infection, in combination with at least one antibacterial agent, which antibacterial agent is administered remote from the si...

The present invention relates to the field of bacteriology. In particular the present invention provides compositions (e.g. comprising a lantibiotic and mupirocin or gentamicin) and methods of treating (e.g. killing or inhibiting growth of) bacteria. For example the present invention provides pharmaceutical compounds (e.g. comprising a lantibiotic and mupirocin or gentamicin) and methods of using the same in research therapeutic and drug screening applications.

This invention relates to methods for treating bacterial infection, which methods find utility in the treatment of, for example, infected ulcers, optionally infected diabetic ulcers. In particular, this invention relates to treating bacterial infection, for example, infected diabetic ulcers by topical administration of at least one aminoglycoside antibiotic at the site of infection, in combination with at least one antibacterial agent, which antibacterial agent is administered remote from the si...

The present invention provides a method of preventing and/or treating a wound infection by introducing to a wound a clear depot comprising a hydrophilic water-soluble pharmaceutically active agent(s) selected from the group consisting of vancomycin gentamicin and a mixture thereof water a phospholipid an oil a pH adjusting agent and a viscosity modifying agent wherein the water present in the viscous depot is no more than about 4 wt % no more than about 2 wt % or no more than about 0.5 wt % of w...